FDA gets more Money

Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
The US Food & Drug Administration's (FDA) budget for the fiscal year (FY) 2018 will be higher than the one for the FY 2017. This was approved by the U.S. Senate Subcommittee on Appropriations. The authority's budget is part of the Agriculture Appropriations Bill and includes 2.8 billion US$ discretionary funding for the FDA. This is 1 million over the FY2017 budget. Including user fee revenues, total FDA funding will be 5.2 billion US$ (which is 491 million US$ above FY2017). The bill also provides 60 million US$ as authorized in the 21st Century Cures Act.
Related GMP News
12.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance